Heren Health300550.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Heren Health (300550.SZ) trades at a P/E of 182.00x, P/B of 3.21x, P/S of 11.30x, and a dividend yield of 0.22%.
Longitudinal percentile comparison: P/E sits at the 98th percentile over the trailing 10Y window (vs. 94th percentile over 3Y); P/B sits at the 36th percentile over the trailing 10Y window (vs. 57th percentile over 3Y); P/S sits at the 70th percentile over the trailing 10Y window (vs. 84th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 82nd percentile within its industry and the 90th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.22%, ranking at the 81st percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 62.3 points — relying on either metric alone could be misleading. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Heren Health operates in the Computer sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300550 · SZSE: 300550 · 300550
Want the full picture on whether Heren Health (300550.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 182.00 | ||||||
| P/B (MRQ) | 3.21 | ||||||
| P/S (TTM) | 11.30 | ||||||
| Dividend Yield | 0.22% | ||||||
| Buyback + Div Yield | 0.22% |